Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-month Single-arm Real-world Study to Determine the Safety and Efficacy of Lecanemab in Patients With Early Alzheimer's Disease

NCT07034222 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07034222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-month Single-arm Real-world Study to Determine the Safety and Efficacy of Lecanemab in Patients With Early Alzheimer's Disease
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 1, 2024
Completion date
January 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease(ad)